Vaccination Recommendations for a 50-Year-Old Woman Without Prior Chickenpox
Yes, she should receive both the varicella vaccine (2-dose series) to prevent primary chickenpox infection AND the recombinant zoster vaccine (Shingrix, 2-dose series) to prevent shingles, as these vaccines serve distinct purposes and are both indicated for her age and immunity status. 1, 2
Varicella (Chickenpox) Vaccination
She requires the varicella vaccine because she has no evidence of immunity to varicella. 1
- Adults without evidence of immunity should receive a 2-dose series of varicella vaccine administered 4-8 weeks apart. 1
- Evidence of immunity includes: U.S. birth before 1980 (which does not apply to her as a 50-year-old in 2024), documentation of 2 doses of varicella-containing vaccine, provider-verified history of varicella or herpes zoster, or laboratory evidence of immunity. 1
- Since she has never had chickenpox and presumably lacks these criteria, she needs primary varicella vaccination. 1
Critical Caveat
The varicella vaccine is a live-attenuated vaccine and is contraindicated in pregnancy and severe immunocompromising conditions. 1, 3 Screen for these conditions before administration.
Recombinant Zoster Vaccine (Shingrix)
She should also receive Shingrix because she is 50 years old, which meets the routine vaccination age threshold. 1, 2
- Routine vaccination with RZV (Shingrix) is recommended for all adults aged 50 years or older as a 2-dose series administered 2-6 months apart (minimum interval 4 weeks). 1
- Shingrix is indicated for prevention of herpes zoster (shingles), NOT for prevention of primary varicella infection. 2
- The recombinant zoster vaccine demonstrates 91.3% efficacy against herpes zoster in adults 50 years and older, with sustained protection over 11+ years of follow-up. 2, 4
- RZV is significantly more effective than the older live zoster vaccine (Zostavax), with efficacy rates of 85% versus 46% in real-world effectiveness studies. 5
Timing Considerations
Administer both vaccines, but coordinate timing appropriately:
- There is no contraindication to administering varicella vaccine and Shingrix during the same visit, as one is a live vaccine and the other is a non-live recombinant vaccine. 1
- However, if she has previously received the live zoster vaccine (Zostavax), RZV should be administered at least 2 months after ZVL. 1
- The varicella vaccine series (2 doses, 4-8 weeks apart) can be completed independently of the Shingrix series (2 doses, 2-6 months apart). 1
Why Both Vaccines Are Necessary
These vaccines serve completely different purposes and do not substitute for each other:
- Varicella vaccine prevents primary chickenpox infection, which she remains susceptible to having never had the disease. 1, 3
- Shingrix prevents reactivation of latent varicella-zoster virus as shingles, which requires prior VZV infection (either from natural chickenpox or vaccination). 2, 4
- Shingrix has a limitation of use clearly stating it is NOT indicated for prevention of primary varicella infection. 2
- The varicella vaccine may eventually reduce herpes zoster risk by establishing controlled latency, but this is not its primary indication and Shingrix provides superior protection against shingles. 3, 4
Safety Profile
Both vaccines have acceptable safety profiles:
- Varicella vaccine causes mostly mild local reactions and is generally well-tolerated in adults. 1, 3
- Shingrix causes more frequent local injection-site reactions and systemic symptoms (fatigue, myalgia, headache) compared to the live zoster vaccine, but these are transient. 6, 5
- Rare adverse events with Shingrix include Guillain-Barré syndrome (less than 1% incidence). 5
Common Pitfall to Avoid
Do not assume that receiving Shingrix eliminates the need for varicella vaccination in a varicella-naive adult. She remains susceptible to primary chickenpox infection, which can be severe in adults, and Shingrix does not protect against this. 2